{"id":39995,"date":"2020-11-09T22:59:00","date_gmt":"2020-11-09T21:59:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=39995"},"modified":"2026-01-06T00:50:42","modified_gmt":"2026-01-05T23:50:42","slug":"tg4001-tipapkinogene-sovacivec-and-avelumab-for-recurrent-metastatic-r-m-human-papilloma-virus-hpv-16-cancers-clinical-efficacy-and-immunogenicity","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/tg4001-tipapkinogene-sovacivec-and-avelumab-for-recurrent-metastatic-r-m-human-papilloma-virus-hpv-16-cancers-clinical-efficacy-and-immunogenicity\/","title":{"rendered":"TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent\/metastatic (R\/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity"},"content":{"rendered":"\n<p class=\"eplus-wrapper wp-block-paragraph\"><br>J\u00e9r\u00e9my B\u00e9guin, et al.<br>Molecular Therapy Oncolytics, September 2020 &#8211; <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33072863\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Read the article<\/strong><\/a><br><em>Publication<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>J\u00e9r\u00e9my B\u00e9guin, et al.Molecular Therapy Oncolytics, September 2020 &#8211; Read the articlePublication<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,133,5,23],"tags":[],"class_list":["post-39995","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-133","category-publication-fr","category-tg4001-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"J\u00e9r\u00e9my B\u00e9guin, et al.Molecular Therapy Oncolytics, September 2020 &#8211; Read the articlePublication","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/39995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=39995"}],"version-history":[{"count":2,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/39995\/revisions"}],"predecessor-version":[{"id":40006,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/39995\/revisions\/40006"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=39995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=39995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=39995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}